Target
Sigma non-opioid intracellular receptor 1
Ligand
BDBM321286
Substrate
n/a
Meas. Tech.
Binding Assay to Sigma Receptors
Ki
3.60±n/a nM
Citation
 Melnyk, PVermersch, PCarato, POxombre-Vanteghem, BZephir, HDonnier-Marechal, M Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases US Patent  US10179761 Publication Date 1/15/2019 
Target
Name:
Sigma non-opioid intracellular receptor 1
Synonyms:
Aging-associated gene 8 protein | OPRS1 | SGMR1_HUMAN | SIG-1R | SIGMAR1 | SR-BP | SR31747-binding protein | SRBP | Sigma 1-type opioid receptor | Sigma opioid receptor | Sigma1R | hSigmaR1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25124.85
Organism:
Homo sapiens (Human)
Description:
Q99720
Residue:
223
Sequence:
MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP
  
Inhibitor
Name:
BDBM321286
Synonyms:
N-(2-(benzyl(methyl)amino)ethyl)-4-nitrobenzamide | US10179761, Compound 3.1.37
Type:
Small organic molecule
Emp. Form.:
C17H19N3O3
Mol. Mass.:
313.3511
SMILES:
CN(CCNC(=O)c1ccc(cc1)[N+]([O-])=O)Cc1ccccc1
Structure:
Search PDB for entries with ligand similarity: